Oriental Aromatics Limited has informed the Exchange regarding Board meeting held on August 08, 2025.
OAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts less than Nifty Microcap 250 and 4.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Oriental Aromatics approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Standalone revenue from operations rose modestly to ₹22,513.44 lakh from ₹21,575.82 lakh a year ago (about 4.3% growth), but standalone net profit fell sharply to ₹573.50 lakh from ₹1,164.47 lakh (down around 51%). On a consolidated basis, net profit plunged to just ₹50.39 lakh from ₹1,098.02 lakh (down about 95%), dragged down by ₹524.96 lakh in losses from its wholly owned subsidiary Oriental Aromatics & Sons Limited, which recently began commercial production at its new greenfield facility in Mahad. Finance costs nearly doubled year-on-year at the consolidated level (₹806.73 lakh vs ₹405.52 lakh). Standalone EPS stood at ₹1.70 versus ₹3.46 in Q1 FY25. Auditor Lodha & Co LLP issued an unmodified review report on both standalone and consolidated results.
While top-line growth was steady, a steep drop in profitability—especially at the consolidated level due to ramp-up losses at the new Mahad plant and higher interest costs—signals margin pressure and is likely to be viewed negatively by investors in the near term.